AHR and obesity due to melanocortin 4 receptor deficiency: In obesity, studies have demonstrated that AhR mediates DIO and its whole-body deletion in mice protects from diet-induced adiposity and metabolic disorders [48, 49], while AhR has also been reported to have a protective role in HFD-induced hepatic steatosis [50].